Clinical Trial Update: The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Study of SHR-3045 in Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of SHR-3045 in healthy subjects; rheumatoid arthritis is listed as th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• SHR-3045

Snippet

Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd | Conditions: Rheumatoid Arthritis (RA) | Phase 1 | Status: RECRUITING